Suchergebnisse - "Cheng, Juan"

PubPharm (764)

101

Association Between Extracellular Superoxide Dismutase Activity and 1-Year All-Cause Mortality in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease : A Prospective Cohort Study

enthalten in: Frontiers in medicine | 2022

von Li, H. | Hong, W. | Zeng, Z. | +14

102

Brain tumor segmentation in multimodal MRI via pixel-level and feature-level image fusion

enthalten in: Frontiers in neuroscience | 2022

von Liu, Y. | Mu, F. | Shi, Y. | +3

103

In vivo growth of subclones derived from Lewis lung carcinoma is determined by the tumor microenvironment

enthalten in: American journal of cancer research | 2022

von Xu, B. | Wang, X. | Chen, G. | +10

104

Urine metabolomics analysis of sleep quality in deep-underground miners : A pilot study

enthalten in: Frontiers in public health | 2022

von Wen, Q. | Zhou, J. | Sun, X. | +10

105

Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2

enthalten in: Frontiers in public health | 2022

von Zhong, W. | Yang, X. | Jiang, X. | +9

106

Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction

enthalten in: Signal transduction and targeted therapy | 2022

von Wang, Z. | Zeng, F. | Hu, Y. | +30

107

Dex modulates the balance of water-electrolyte metabolism by depressing the expression of AVP in PVN

enthalten in: Frontiers in pharmacology | 2022

von Yang, W. | Li, H. | Cheng, Z. | +5

108

Expression of SH3 and Multiple Ankyrin Repeat Domains Protein 3 in Mouse Retina

enthalten in: Frontiers in cellular neuroscience | 2022

von Xu, Y. | Wang, Y. | Tong, G. | +6

109

Development and Application of Activity-based Fluorescent Probes for High-Throughput Screening

enthalten in: Current medicinal chemistry | 2022

von Cheng, J. | Li, X.

110

Development and Application of Activity-based Fluorescent Probes for High-Throughput Screening

enthalten in: Current medicinal chemistry | 2022

von Cheng, J. | Li, X.